Cellular therapies: what is still missing?
Kidney Int
; 79(11): 1161-3, 2011 Jun.
Article
en En
| MEDLINE
| ID: mdl-21566637
ABSTRACT
Yeagy and colleagues present long-term data from a preclinical model of cystinosis after hematopoietic stem cell transplantation. The results suggest a therapeutic benefit independent of target tissue differentiation but dependent on the level of bone marrow chimerism. The mode of action remains mysterious, but positive effects are seen. Although the work presents a potential therapeutic option for an otherwise dismal disease, the search for the mechanism of action in cellular therapies continues.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Trasplante de Médula Ósea
/
Trasplante de Células Madre Hematopoyéticas
/
Cistinosis
/
Riñón
/
Enfermedades Renales
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
Idioma:
En
Revista:
Kidney Int
Año:
2011
Tipo del documento:
Article